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1. INTRODUCTION 
 Carcinoma Stomach is the main Gastrointestinal Malignancy 
encountered in surgical clinic. The importance of early diagnosis and gastric 
cancer cannot be overemphasised. Early Gastric cancer without lymphnode 
metastasis is highly curable, whereas advanced cancer is associated with a poor 
prognosis. 
 By improved methods of diagnosis, the Japanese had developed mass 
screening programs and have significantly improved their 5 year survival 
statistics. In Japan 50% of gastric cancers treated are early gastric cancers. In 
united states about 20% of the resected specimens show Early gastric cancer. 
 World wide especially in Asia and Eastern Europe, Gastric cancer 
remains the second most common among cancers and is the leading cause of 
cancer deaths. In India carcinoma stomach is the fourth common malignancy 
and second common cause of death due to malignancy. The detection of early 
gastric cancer is still less than 5 to 10% in India. 
 The present study is an attempt to establish the incidence, role of risk 
factors, analyse the symptomatology, stage of disease, mode of various surgical 
treatment and results in our patients and compare them with results abroad.  
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2. AIM OF THE STUDY 
 The aim was to study the following objectives in patients admitted with 
a diagnosis of Gastric Cancer, and operated in Government Kilpauk Medical 
College Hospital and Government Royapettah Hospital, Chennai. 
* To discuss the incidence, causative factors, mode of presentation, 
disease pattern of Gastric carcinoma in our patients. 
* A study of Barium meal examination, upper gastro intestinal 
endoscopy and computerised tomography in the diagnosis of 
Gastric carcinoma. 
* To discuss various surgical modalities in the management of 
gastric cancer. 
* To compare the results with that of world statistics. 
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3.  REVIEW OF LITERATURE 
 Gastric resections were first performed in 1881 by Billroth. Wolfler a 
colleague of Billroth performed a gastroenterostomy the same year. Schlatter 
performed a total gastrectomy in 1897. An attempt at wide lymphatic resection 
was described by Appleby in 1952, who reported a case of a patient with a 
tumor in body of stomach. 
 Prior to the availability of flexible endoscopy in the early 1970's, 
symptomatic patients who had abnormal upper GI series generally went to 
exploratory laparotomy and gastric resection if possible. Breaux et al., reported 
that Diagnostic laparotomies decreased from 23% in the 1950s to 9.4% in the 
1980's. At present date, the diagnostic accuracy of upper GI endoscopy is 
approximately 94% and the need for Diagnostic laparotomy is rare. 
 The majority of gastric cancers are detected at an advanced stage, 
defined as an extension beyond the muscularis propria. The 5 year survival is 
therefore quite low, in the range of 10% to 15%. The mean survival rate of 5 
year in Japan is about 90% to 95% due to the effective screening procedures at 
present.  
 Sedgwick, G.R. Gilles, Dupout and Indians like Sarkar et al., 
B.R.Prabhakar and N.Rangabashyam have studied the age incidence of 
carcinoma stomach. Kniller et al., Lawrence, W. Way and others studied the 
incidence in various socioeconomic group. 
  
4
 Systemic and local recurrences are common even after complete tumor 
resection and extensive lymphadenectomy. Therefore role of multidisciplinary 
approach with adjuvant and neoadjuvant chemotherapy, radiotherapy, 
combined chemoradiation are increasingly evaluated for the management of 
these tumor. 
 Adenocarcinoma of stomach was the leading cause of cancer death 
world wide through most of the twentieth century now ranks second only to 
lung cancer. It is estimated 22,700 new cases are diagnosed annually in U.S 
with approximately 11,800 deaths per year. There has been increasing 
incidence of proximal gastric cancer, annual rate of increase for proximal 
gastric lesions was 4.3% for white men and 4.1% for white women. 
 The highest incidence of stomach cancer can be found in Japan, South 
American and Eastern Europe, with incidence rates as high as 30 to 85 per 
1,00,000 population. In contrast, low incidence areas such as U.S., Israel and 
Kuwait have incidence rates of study of only 4 to 8 cases per 1,00,000 
population. 
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4. FUNCTIONAL ANATOMY OF STOMACH 
 Stomach is the most dilated part of the alimentary tract, it lies mainly in 
the left hypochondrium, Epigastric, umbilical region with much of it under 
cover of lower ribs. 
 It is a muscular bag, and can accommodate 1500 ml or more in adult. 
The junction with the esophagus is the cardia and the most fixed part, pyloric 
opening is at Gastroduodenal junction. Main parts fundus, body and pylorus. 
The stomach is completely invested by peritoneum which passes in a double 
layer from the lesser curvature to the liver as lesser omentum and hanging 
down from the fundus and greater curvature as greater omentum which fuses 
with the transverse colon and mesocolon. 
 Fundus is the part projecting above the level of cardia and is in contact 
with left dome of diaphragm. 
 Body is the largest part extending from the fundus to the angular notch 
(incisura angularis). 
 Pyloric part extends from the angular notch to the gastroduodenal 
junction, consists of proximal dilated portion the pyloric antrum and it narrows 
distally as the pyloric canal which is continued distally as pylorus. The circular 
muscle in the pylorus thickened to form pyloric sphincter. Anterior to pyloric 
sphincter is the prepyloric vein of Mayo, landmark of pyloroduodenal junction. 
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BLOOD SUPPLY 
1. Left gastric artery  : Smallest branch of the coeliac axis 
2. Right gastric artery  : Branch of common hepatic artery 
3. Right gastro epiploic artery : Branch   of   gastroduodenal artery,  
which is the largest branch of 
common hepatic artery 
 
4. Left gastro epiploic  artery : Largest branch of splenic artery 
5. Vasa brevia   : 5 to 7  short  gastric   vessels   from  
splenic artery. 
 
VENOUS DRAINAGE 
 Those corresponding to the right and left gastric arteries terminate in 
portal vein. Those corresponding to left gastroepiploic vein and short gastric 
veins drain into splenic vein. The right gastroepiploic vein drains into superior 
mesentric vein. 
NERVE SUPPLY 
 Parasympathetic : vagus nerve branches. 
LYMPHATIC DRAINAGE 
 The lymphatic vessels of the stomach arise in its submucous and 
subperitoneal layers, and divide into four main sets that accompany 
corresponding blood vessles. 
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Lymphnode stations are divided into 3 groups by Japanese. 
 Group I (Perigastric nodes) 
  1 - Right cardiac 
  2 - Left cardiac 
  3 - Lesser curve side 
  4 - Greater curve side 
  5 - Suprapyloric 
  6 - Infrapyloric 
 Group II (along major vessels) 
  7 - Left gastric artery 
  8 - Common hepatic artery 
  9 - Coeliac artery 
  10 - Splenic hilus 
  11 - Splenic artery 
 Group III 
  12 - Along hepatoduodenal ligament  
  13 - Retroperitoneal nodes 
  14 - At root of mesentry 
  15 - Along Middle colic vessels 
  16 - Para aortic nodes 
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HISTOLOGY 
 Gastric epithelial cells lining the stomach are of columnar type. They are 
filled with mucigenous granules and are responsible for the lubrication of 
contents. 
 Various types of cells in stomach 
 Body   : Parietal cells 
     Chief cells 
 Antrum  : Gastrin `G' cells 
 Entire stomach : `D' cells 
     `ECL' cells 
FUNCTIONS OF VARIOUS CELLS 
1. Parietal cells  : Produce acid (H+) 
2. Chief cells  : Produce pepsinogen 
3. Endocrine cells 
  `G' cells - produce gastrin 
  `D' cells - produce somatostatin 
  `ECL' cells - produce histamine 
 (Enterochromaffin like cells) 
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5. REVIEW OF GASTRIC CARCINOMA 
EPIDEMIOLOGY 
 Gastric Cancer is the 10th most common cancer in the United states, the 
incidence of which has been decreasing over last 70 years. It is estimated 
22,000 patients will develop the disease each year and 13,000 of those will die. 
* The male preponderance (2:1) is encountered world wide. The incidence 
also increase with age. 
* The disease is most frequently seen in the age group between 50 and 70, 
with a peak age about 60 for both sexes. Gastric cancer is rare under the 
age of 30 years. 
* One of the most striking epidemiologic observations has been the 
increasing incidence of adenocarcinomas involving the proximal 
stomach and distal esophagus. These tumors have different etiological  
factors for example, gastric body lesions are associated with low acid 
production and H.Pylori infection, whereas cardia lesions are not 
associated with either. 
* A decreased incidence has been observed with increased consumption of 
fresh vegetables and fruits.  
* The 5 year survival is 17% overall and ranges from 2% when associated 
with distant metastasis to 55% when confined to stomach. The 5 year 
survival is 18% when regional lymph nodes are involved. 
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PREDISPOSING FACTORS 
TABLE - 5.1 
 
 
 Definite (Surveillance Suggested) 
  Familial adenomatous polyposis 
  Gastric adenomas 
  High grade dysplasia (on biopsy) 
 Definite 
  Chronic atrophic gastritis 
  Gastric metaplasia 
  Helicobacter pylori infection 
  HNPCC 
 Probable 
  Pernicious anemia 
  Tobacco smoking 
  Salted, pickled, smoked food 
  Menetrier's disease 
  H/o. subtotal gastrectomy (> 20 years) 
  Peutz jeghers syndrome 
 Questionable 
  Benign gastric ulcer 
  Hyperplastic polyps 
 
HELICOBACTER PYLORI 
* Helicobacter pylori is a curved, spirochete like organisum identified in 
the gastric mucus adherent to the surface epithelium and in the pits but 
without evidence of tissue invasion. 
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* H.Pylori produces a six fold increased risk for carcinoma stomach. 
 H.Pylori promotes carcinogenesis in a variety of ways. 
1. Exposure of mucosal cells to oxidative stress of free radicals. 
 2. Enhanced progression of normal to metaplastic epithelium. 
3. Secretion of ascorbic acid is also decreased in H.Pylori induced, 
type B chronic gastritis that allows greater degree of intragastric 
NOC formation. 
TABLE - 5.2 
 
 
 
 
  
 
 
H.pylori is associated in 80% cases of intestinal type cancers and 32% 
cases of Diffuse type cancers. 
 
H.Pylori infection 
 
 
Chronic inflammation 
with active, chronic gastritis 
 
 
Increased risk of DNA 
synthesis and cell proliferation 
 
 
        Dietary                   Genetic 
     factors     Somatic mutations   predisposition 
 
 
Gastric cancer 
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 H.pylori is not associated with carcinoma involving cardia and fundus of 
stomach. 
2. FAMILY STUDIES IN GASTRIC CANCER 
* Family History of gastric cancer is observed in 10% - 15% of 
cases especially with diffuse type. 
* Elevated risk (2 to 3 fold) is observed in first degree relatives. 
* Diffuse gastric cancer is found predominantly in patients under 
the age of 40 years and is associated with an equal sex ratio, 
Blood group A and poor prognosis. 
* In Hereditary non polyposis colorectal cancer (HNPCC) type II 
(Lynch syndrome) 5% to 10% of all carcinomas originate from 
the stomach. 
* In Juvenile polyposis there is 12% chance of gastric cancer. 
* In FAP (Familial adenomatous polyposis) the risk of Ca.stomach 
is 10 fold higher than general population. 
3. GENETIC FACTORS IN GASTRIC CANCER 
 A number of genetic analysis have been carried out in primary gastric 
carcinoma samples and a list of useful information obtained (Table - 3). 
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TABLE - 5.3 
Karyotype abnormalities Breakpoints at 3p21 
DNA Aneuploidy Found in 50% - 75% 
 
Gene amplification 
Cerb B-2 / neu  :  5% to 7% 
Ksam   : 20% in diffuse type 
C-met   : Occasionally 
Oncogene Mutation ras mutations found in <7% cases 
 
Tumor suppressor gene 
P53 - LOH in 60% to 70% 
 Mutation in 38% to 67% 
APC - LOH in 30% to 40% 
 Mutation in 7% to 21% 
PCC - LOH in 20% to 60% 
Microsatellite instability Found in 15% - 39% 
 
4. MISCELLANEOUS 
a. Chronic atrophic gastritis : 
Two to three told increased risk of Gastric cancer, particularly 
intestinal type. 
 b. Pernicious Anemia : 
  They reported a 1% to 10% gastric cancer in long term studies. 
 c. Gastric ulcer : 
Malignant transformation is quite rare, occurring in less than 1% 
cases. 
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Such malignant change is defined as ulceration and scarring that 
extends into muscularis propria with carcinoma located at the 
edge but not the base of ulcer. 
 d. Post gastrectomy : 
Gastric carcinoma arising in the post surgical gastric remnant 
after distal gastrectomy may be defined as a cancer occurring 5 or 
more years after the surgical procedure. 
In an analysis of 20 studies reported by Offerhaus an overall two 
fold increased risk was reported. Typically these tumors arise 
after 20 years period and when operated in young age (Under 45). 
 e. Menetrier's Disease (Hypertrophic gastropathy) : 
Rare, idiopathic disease characterised by rugal fold hypertrophy, 
hypochlorhydria, protein - losing enteropathy and hyperplasia of 
surface foveolar mucus cells. 15% of these cases describe an 
association with gastric carcinoma. 
 f. Gastric epithelial polyps : 
  Two Types : 
High malignant potential adenomas and low malignant potential 
hyperplastic polyps. 
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TABLE - 5.4 
 
 
 
 
 
 
 
* Upto 40% of adenomas may develop malignancy especially in larger 
tumors greater than 2 cm. In contrast, the prevalence in hyperplastic 
polyps is low (0.4%), typically occurring only in large stalked lesions 
over 2 cm in size. 
 g. Dysplasia : 
Dysplasia is defined by presence of cytologic atypia, abnormal 
cellular differentiation and disorganised architecture. It is 
generally classified into mild, moderate or severe. Gastric 
dysplasis is detected in biopsy or resection specimen. 
 The most important histological marker of gastric cancer is dysplasia. 
There are two types : 
 
Neoplastic Polyps  : (8.2%) 
 
  Tubular adenomas 
  Villous adenomas 
  Tubulovillous adenomas 
  Mixed adenoma - hyperplastic polyp. 
 
Hyperplastic polyps  :  (90%) 
 
Hamartomatous polyps Peutz jeghers polyps 
    Juvenile polyposis 
 
Foveolar adenoma  Gardners syndrome 
 
Fundus gland polyps unclassified 
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 Type A : 
Affects metaplastic gastric epithelium and can lead to the development 
of intestinal type gastric cancers. 
Type B : 
Lergely made up of undifferentisted round cells with a clear or 
amphophilic cytoplasm lacking a brush border. 
* Severe dysplasia is regarded nowadays as insitu gastric cancer. 
PREMALIGNANT LESIONS 
 A premalignant condition is a histologic change in healthy mucosa that 
places mucosa at risk of malignancy (Table - 5). 
TABLE - 5.5 
 
 
 
 
 
 
 
  * Persistent infection with H.pylori 
 
  * Atrophic gastritis and pernicious anemia 
 
  * Previous partial gastrectomy 
 
  * Adenomatous and hyperplastic polyps 
 
  * Familial polyposis 
 
  * Hypogamma globulinemia 
 
  * Blood group A 
 
  * Type III intestinal metaplasia 
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TYPES OF INTESTINAL METAPLASIA 
 Depending on the degree of cell differentiation and abnormal mucus 
production. 
Type I (Complete)- Mature absorptive and goblet cells. The latter 
secrete sialomucin (Normal) 
Type II (Incomplete) - Absorptive cells are few or absent. Columnar 
intermediate cells of dedifferenitation are present. 
The goblet cells secrete sialomucins and 
sulphomucins (abnormal) 
Type III (Incomplete) - Cell de-differentiation is more. Intermediate cells 
secrete predominently sulphomucins (abnormal). 
The goblet cells secrete sialomucins and 
sulphomucins. A variable degree of disorganised 
glandular architecture is present. 
Type III intestinal metaplasia has been reported in relatives of patients 
with gastric carcinomas and in patients with pernicious anemia. 
PATHOLOGY 
 The vast majority of gastric carcinomas arise from mucus secreting 
basal cells of the crypts, usually in the setting of chronic atrophic gastritis with 
intestinal metaplasia. 
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TABLE - 5.6 
 
 
 
 
 
 
 
 
 In order of frequency : 
  Carcinomas (90 - 95%) 
  Lymphomas (4%) 
  Spindle cell tumors (2%) 
  Carcinoids (3%) 
Among the carcinomas, Adenocarcinoma is the common type 
 1. Differentiated - Papillary, Tubular 
 2. Undifferentiated - Signet ring cell, anaplastic type  
 
WHO Histological typing of malignant epithelial 
tumors of the stomach. 
 
ADENOCARCINOMA 
  
  Papillary 
 Tubular 
  Mucinous 
 Signet ring cell 
Adenosquamous 
Squamous cell 
Small cell 
Undifferentiated 
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CLASSIFICATION AND PERCENTAGE OF TUMOR TYPES 
 Early Gastric Garcinoma 
 Early gastric cancer is defined as Adenocarcinoma limited to the mucosa 
and submucosa of the stomach regardless of lymphnode status. The entity is 
common in Japan where gastric cancer is the number one cause of cancer 
death. 
 Approximately 10% of patients with early gastric cancer will have 
lymphnode metastasis. 
TABLE - 5.7 
 
 
 
 
 
 
 
 Approximately 70% of early gastric cancers are well differentiated and 
30% are poorly differentiated. 
 
Classification for Early Gastric Cancer : (Japanese Classification) 
 
Type I  : Exophytic lesions (extends into gastric lumen) 
 
Type II : Superficial variant 
 
   IIA - Elevated (height less than the thickness of  
adjacent mucosa) 
 
IIB - Flat lesions 
 
IIIC - Depressed lesion (Eroded but not ulcerated) 
 
Type III : Excavated lesions (ulcerated tumors) 
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ADVANCED GASTRIC CARCINOMA 
 They include lesions that share common feature of invasion through the 
submucosa into the muscularis propria and beyond. 
BORRMANN'S CLASSIFICATION OF ADVANCED GASTRIC 
CANCER 
TABLE - 5.8 
Types Macroscopic description 
I Polypoid or fungating 
II Ulcerative, circumscribed with everted margins 
III Ulcerative, noncircumscribed with ill defined margins 
infiltrating gastric wall (CRATERIFORM) 
IV Diffuse imfiltrating type 
V. Unclassified. 
 
 Types II and III are the most common, followed by  Type IV. 
 Polypoidal type are least common. 
STOUT CLASSIFICATION 
 1. Ulcerative (most common) 
 2. Fungating (Polypoid) 
 3. Superifical spreading 
 4. Diffusely infiltrating 
This is purely morphological classification with no prognostic 
significance hence fallen out of favour. 
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MING'S CLASSIFICATION 
 1. Expanding (67%) 
 2. Infiltrative (33%) 
HISTOLOGIC CLASSIFICATION 
 LAUREN'S CLASSIFICATION : (DIO CLASSIFICATION) 
 Diffuse  - 33% 
 Intestinal - 53% 
 Others  - 14% 
* Intestinal type : 
Tumor cells are typical large and pleomorphic with large 
hyperchromatic nuclei. Neoplastic glands may exhibit focal cytoplasmic 
or intraluminal mucin secretions. Good prognosis. It includes 
differentiated carcinoma. 
* Diffuse type : 
Clusters or solitary uniform cells, poorly differentiated cells that 
infiltrate the gastric wall. Gland formation is uncommon. Signet ring 
pattern (Intracellular mucin with pushed out nuclei) have a poor 
prognosis. It includes undifferentiated carcinomas and signet ring cell 
carcinoma. 
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TABLE - 5.9 
CLINICO PATHOLOGICAL DIFFERENCES BETWEEN INTESTINAL 
AND DIFFUSE GASTRIC CARCINOMAS 
 
 Intestinal Diffuse 
Histogenesis Areas of Intestinal 
metaplasia 
Normal gastric mucosa 
Lymphocytic infiltration 
of the stroma 
Present Absent 
Early Cancer Protruding type Flat, depressed or 
excavated 
Advanced cancer Borrmann's type I-III Borrmann's type IV-III 
Infiltration Localised Difuse 
Peritoneal dissemination Infrequent Frequent 
Hepatic metastasis Nodular Diffuse 
Sex Incidence More common in Males More common in 
Females 
Age Incidence More common in the 
elderly 
More common in the 
young 
Association with Blood 
group `A' 
No Yes 
Association with 
pernicious anemia 
No Yes 
Genetic prediposition No Yes 
DNA ploidy pattern Diploid Polyploid 
Prognosis Survival better than the 
Diffuse 
Dismal 
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BRODER'S CLASSIFICATION 
 Broder's classification grades cells from grade I (well differentiated) to 
grade IV (anaplastic). 
SITE OF PREDOMINANCE 
 Common sites in India, 
 Prepyloric and pyloric region  - 65% 
 Body of stomch    - 25% 
 Fundus and OG junction  - 10% 
* But in western countries proximal stomach tumours are increasing in 
incidence few decades and attained the most common site of Gastric 
cancer. 
* In high socio economic status, proximal tumors are common. 
* In India and in Japan Distal gastric cancers are still common. 
* Tumors are also more common on the lesser curvature side then graster 
curvature side (40% vs 10%). 
* Distal cancers are related by diet and environmental factors with 
histologic type predominently Intestinal hence are `epidemic'. 
* Proximal cancers are genetically related with diffuse type and hence are 
endemic. 
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MODE OF SPREAD 
TABLE - 5.10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Liver is the most frequent site of metastasis, being involved almost 
twice as frequently as the peritoneum or omentum. 
 
I. Direct Spread : 
 
  Lesser and greater omentum 
  Liver and diaphragm 
  Pancreas 
  Spleen 
  Biliary tract 
  Transverse colon 
  Oesophagus (via submucosal lymphatics) 
  Diaphragm (via subserosal lymphatics) 
 
II. Nodal Metastasis : 
 
  Local  
  Distant 
   Virchow's node (Left supraclavicular) 
   Irish's node (Left axillary) 
 
III. Vascular metastasis : 
 
  Liver (40%) 
  Lung and Pleura (40%) 
  Bone (10%) 
  Brain 
 
IV. Peritoneal metastasis : 
 
  Disseminated 
  Pelvic 
   Krukenberg tumor - ovary 
   Blumer's rectal shelf 
  
25
CLINICAL FEATURES 
TABLE - 5.11 
Symptom Frequency (%) 
Weight loss 62% 
Abdominal pain 52% 
Nausea 34% 
Anorexia 32% 
Dysphagia 26% 
Melena 20% 
Early satiety 18% 
Ulcer symptoms 17% 
Hematemesis 15% 
 
 From Wanebo et al., (ACS - Patient care study) 
EARLY GASTRIC CANCER 
 * Asymptomatic 
 * Epigastric pain (2/3 cases) 
 * Nausea and vomiting (40%) 
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 * Anorexia (1/3) 
 * Weight loss, hematemesis or melena 
 Mean duration of symptoms - 21 to 36 months. 
ADVANCED GASTRIC CANCER 
 Abdominal pain is the first symptom 
 Weight loss, anorexia, early satiety, 
 Bloating, diarrhoea or bleeding 
DEPENDING ON THE SITE OF LOCATION 
 1. OG junction  - Dysphagia, loss of weight 
 2. Pyloric region - Gastric outlet obstruction (Vomiting) 
ON EXAMINATION 
 1. Epigastric mass 
 2. Liver secondaries 
 3. Ascites 
 4. Obstructive jaundice 
 5. Krukenberg tumor (Deposits over the ovary) 
 6. Trousseau's sign (thrombophlebitis of veins) 
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 7. Troisier's sign (left supraclavicular node enlargement) 
 8. Sister Mary Joseph nodule (Hard nodule at the umbilicus) 
 9. Blumer's shelf (Deposits in the rectovesical pouch) 
 10. Pleural effusion  
 11. Paraneoplastic signs : 
  * Acanthosis nigricans 
* Leser Trelat sign (appearance of watery keratosis & 
pruritus) 
  * Dermatomyositis 
STAGING OF CARCINOMA STOMACH 
 Two types of staging system are used at present. 
1. AJCC (American Joint Committee on Cancer Staging of Gastric 
Cancer, 2002) 
 TNM staging based on primary tumor, regional lymphnodes, 
distant metastasis. 
2. Cancer staging in an alternate way by Japanese known as PHNS 
staging. Four factors are used, namely, the grade of peritoneal 
dissemination (Pfactor), the presence of hepatic metastasis 
(Hfactor), lymph node involvement (Nfactor) and serosal 
invasion (Sfactor). 
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TABLE - 5.12 
AMERICAN JOINT COMMITTEE ON CANCER STAGING OF 
GASTRIC CANCER, 2002 
 
Definition of TNM 
PRIMARY TUMOR (T) 
TX Primary tumor cannot be assessed 
T0 No evidence of primary tumour 
Tis Carcinoma in situ : intraepithelial tumor without invasion of the 
lamina propria 
T1 Tumor invades lamina propria or submucosa 
T2 Tumor invades muscularis propria or subserosa 
T2a Tumor invades muscularis propria 
T2b Tumor invades subserosa 
T3 Tumor penetrates serosa (visceral peritoneum) without invasion of 
adjacent structures 
T4 Tumor invades adjacent structures 
REGIONAL LYMPH NODES (N) 
NX Regional lymph node(s) cannot be assessed 
N0 No regional lymph node metastasis 
N1 Metastasis in 1-6 regional lymph nodes 
N2 Metastasis in 7-15 regional lymph nodes 
N3 Metastasis in more than 15 regional  lymph nodes 
DISTANT METASTASIS (M) 
MX Presence of distant metastasis cannot be assessed 
M0 No distant metastasis 
M1 Distant metastasis 
STAGE GROUPING 
0 Tis N0 M0 
IA T1 N0 M0 
IB T1 
T2a/b 
N1 
N0 
M0 
M0 
 
II 
T1 
T2 
T3 
N2 
N1 
N0 
M0 
M0 
M0 
 
IIIA 
T2a/b 
T3 
T4 
N2 
N1 
N0 
M0 
M0 
M0 
IIIB T3 N2 M0 
IV T4 
T1-3 
Any T 
N1-3 
N3 
Any N 
M0 
M0 
M1 
 
TNM, tumor, node, metastasis. 
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TABLE - 5.13 
PHNS  STAGING SYSTEM 
 
P FACTOR 
P0 No evidence of peritoneal spread 
P1 Peritoneal spread limited to supracolic area; includes 
greater omentum, not diaphragm 
P2 Small number of nodules below mesocolon or diaphragm 
P3 Numerous nodules below mesocolon or diaphragm 
H FACTOR 
H0 No metastasis to liver 
H1 Metastasis limited to one lobe 
H2 Small number of metastasis to both lobes 
H3 Many metastasis to both lobes 
N FACTOR 
N0 No lymph node involvement 
N1 Group 1 involvement 
N2 Group 2 involvement 
N3 Group 3 involvement 
N4 Extending beyond group 3 
S FACTOR 
S0 No penetration to serosa 
S1 Minimal involvement of serosa 
S2 Obvious involvement of serosa 
S3 Obvious involvement of serosa and neighbouring organs. 
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Stage I PoHoNoSo 
Stage II PoHoN1N2S1 
Stage III PoHoN3S2 
Stage IV >P1H1N4S3 
 
 The Japanese staging system extensively classifies 18 lymphnode region 
into favour N categories depending on their relation to the primary tumor and 
anatomic location. 
PROGNOSIS 
 The prognosis for patients with gastric cancer depends on the extent of 
the disease and on treatment. 
Extension of the Disease, whether local or regional, adversely affects 
survival. Lymphnode involvement is adverse prognostic factor. 
The important prognostic factor in patients without detectable metastasis 
is depth of invasion of the stomach wall by the tumor. Other significant but 
lesser prognostic variables are the type of cancer (Intestinal or diffuse), 
Location of tumor (growths of the cardia having a poorer prognosis than 
lesions of the middle and lower third) and the histological type (degree of 
differentiation). 
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PROGNOSTIC DETERMINANTS OF GASTRIC CANCER 
TABLE - 5.14 
Depth in invasion Prognosis 
Mucosa (in situ) 100% 5 year survival 
Mucosa + muscaris mucosa 80 - 95% 5 years survival 
Submucosa 75 - 80% 5 years survival 
Muscularis propria 0 - 40% 5 years survival 
Size of primary  
< 2cm 85% 5 year survival 
> 4 cm 0 - 50% 5 year survival 
Histological types  
Intestinal (differentiated) Favourable 
Diffuse (undifferentiated) Unfavourable 
Nodal Status  
No involvement 80% 5 years survival 
Metastasis 0 - 40% 5 years survival (depending 
on level of node involvement) 
 
INVESTIGATIONS 
 
 
 
 
 
 
Investigations in carcinoma stomach are based on the following 
headings. 
 
I. Diagnostic : 1. Barium meal 
    2. UGI endoscopy 
 
II. Staging : 1. USG abdomen 
    2. CT scan abdomen 
   3. MRI 
   4. Endoscopic ultrasound 
   5. Laparoscopy 
 
III. Others  : 1. Routine investigations 
  2. Serum markers 
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1. BARIUM MEAL EXAMINATION 
 Radio diagnosis is accurate in 90 percent of pyloric growth, 70 percent 
of the cardia growth and 60 percent of growth in body. Single or double 
contrast baruim studies have a sensitivity of 70% to 75% and the specificity is 
about 90% in advanced cases. There studies have a low sensitivity for 
superficial gastric mucosal cancers. A non distensible stomach suggests a 
diffusely infiltrating cancer (LINITIS PLASTICA). 
2. UPPER GI ENDOSCOPY 
 This has gradually replaced the barium meal study and has become the 
gold standard investigation for diagnosis. Visual inspection alone will diagnose 
only 50% of early gastric cancer. A single biopsy from a suspicious lesion may 
be positive in 70% to 100% of cases. Diagnostic accuracy is dramatically 
improved by obtaining six to eight biopsies from the edge and base of ulcer. `J' 
manoever is used to visualize the lesions in the cardia / fundus of stomach. 
3. ENDOSCOPIC ULTRASOUND (EUS) 
 EUS uses high frequency sound waves (7.5 to 12 MHZ) that provide 
excellent spatial resolution. EUS is superior to CT for local staging although 
they are complimentary to each other. EUS can be used to accurately 
differenitate early from advanced gastric carcinoma in 90% to 99% of cases. 
`T' staging is 78% and `N' staging is 70% accurate with EUS. 
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4. COMPUTERISED TOMOGRAPHY (CT SCAN) 
 CT scan cannot differentiate between T1 and T2 lesions. Lymphatic 
metastasis can be diagnosed with greater than 90% specificity but sensitivity 
varies from 48% to 91%. CT scan fails to identify local invasion, cannot 
identify small peritoneal metastasis, tumor involvement in normal and near 
normal sized nodes. Sensitivity for detecting tumor invasion into colon (or) 
mesocolon and pancreas was 76% and 50% respectively. 
5. MRI SCAN 
 It may be superior to CT scan in `T' staging in delineating the stomach 
wall. 
6. DIAGNOSTIC LAPAROSCOPY 
 More sensitive in detecting Hepatic, nodal and peritoneal metastasis. An 
extensive laparoscopic procedure, while quite accurate, has not been widely 
adopted. 
7. TUMOR MARKERS 
 The only reliable marker is CA72 4 which correlates well with tumor 
burden and lymphnode involvement. Others CEA, CA199, CA125, CA724 are 
used to detect the recurrence and progression of tumor. 
8. ROUTINE INVESTIGATIONS 
 - Anemia (due to blood loss) 
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 - Abnormal liver function test (hepatic metastasis) 
 - Radiographic evidence of Bone or pulmonary metastasis. 
TREATMENT : Three therapeutic modalities 
 1. Surgery 
 2. Chemotherapy 
 3. Radiotherapy 
 Depends on the staging of tumor 
I. OPERATIVE TREATMENT 
 1. Curative 
 2. Palliative 
1. CURATIVE RESECTIONS : 
 Extent of Gastric Resection : 
 Resection which provides a 2 cm margin for early or well circumscribed 
tumors and 5 cm for infiltrative advanced lesions is adequate. 
 A total gastrectomy is necessary for the following  
i. When the proximal distance from the cardia is less than 
the required length to achieve a safe tumor free margin. 
ii. Neoplasm involves two or all three sectors of stomach. 
iii. Diffuse carcinoma (Borrmann IV) irrespective of size. 
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a. FOR PROXIMAL GASTRIC CANCER : 
Though radical upper gastrectomy can be performed for these patients 
because of functional problems and alkaline reflux gastritis it is better to 
perform a radical total gastrectomy with resection of involved part of 
Esophagus. 
b. FOR MIDDLE THIRD LESIONS : 
 Radical lower gastrectomy is performed if an adequate proximal 
clearance is possible or else a Radical total gastrectomy performed. 
c. FOR LOWER THIRD LESIONS : 
 Radical lower gastrectomy with 1-2 cm of the duodenum is the preferred 
method. 
RECONSTRUCTIONS 
After Distal Gastrectomy : i. Billorth I (Gastroduodenal) 
 
ii. Billroth II Polya (Gastrojejunal)  
 
After Total Gastrectomy : i. Single   isoperistaltic  jejunal  
interposition  between oesphagus and  
Duodenum 
ii. Simple  Roux-en-y  oesophago 
jejunostomy 
     iii. Hunt Laurence  Roux-en-y pouch. 
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EXTENT OF LYMPHNODE DISSECTION 
TABLE - 5.15 
Site D1 D2 D3 
Lower 
Third 
Lesions 
3. Lesser Curvature 
4. Greater curvature 
5. Supra Pyloric 
6. Infra Pyloric 
1. Right cardiac 
7. Left gastric artery 
8. Hepatic 
9. Coeliac 
1-11 as in R1, & R2 and 
12. Hepatoduodenal 
ligament 
Midle 
Third 
Lesions 
1. Right cardiac 
2. Left cardiac 
3. Lesser Curvature 
4. Greater curvature 
5. Supra Pyloric 
6. Infra Pyloric 
7. Left gastric artery 
8. Hepatic 
9. Coeliac 
10. Splenic hilar 
11. Splenic artery 
13. Retropancreatico-
duodenal 
14. Root of mesentry 
15. Midcolic 
16. Periaortic 
Upper 
Third 
Lesions 
(include 
cardia) 
1. Right cardiac 
2. Left cardiac 
3. Lesser Curvature 
4. Greater curvature 
     & short gastric 
5. Supra Pyloric 
6. Infra Pyloric 
7. Left gastric artery 
8. Hepatic 
9. Coeliac 
10. Splenic hilar 
11. Splenic artery 
11a. Para oesophageal 
(Cardia lesions) 
 
 
  
D1 Resection - Lymphnode clearance is continued to the primary group 
of nodes 
 
D2 Resection - Additional clearance of lymph nodes along the main 
arteries. Pancreatectomy and splenectomy are not done 
nowadays due to increased morbidity and mortality. 
Pancreas and spleen preserving D2 resection is possible 
and splenectomy is done only in cases with frank 
lymphnode mets or infiltration in splenic hilum. 
 
D3 Resection - Even further clearance of nodes of Group III which is not 
practiced nowadays. 
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Randomized trials like Bonenkamp et al and Cuschieri et al., had proved 
there is no survival advantage of D2 resection over D1 resection, hence D2 
resection is not favored except in Japan. 
In AJCC system Group III nodes are considered as distant metastasis 
(M1). 
2. PALLATIVE PROCEDURES 
 Signs of Inoperability 
1. Fixation to pancreas or posterior abdominal wall. 
2. Involvement of mesentry, especially the origin of superior 
mesentric vessels. 
3. Gross local involvements of lymphnodes leading to fixity. 
4. Retrograde spread to preaortic lymphnodes. 
5. Multiple secondaries in liver 
6. Peritoneal seedings and pelvic deposits 
Symptoms which may call for palliation 
1. Pain   - Obstructive, ulcer type, infiltrative 
2. Vomiting - Obstructive, non - obstructive 
3. Dysphagia 
4. Bleeding 
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PALLIATIVE PROCEDURES FOR GASTRIC CANCER 
 
 
 
 
 
 
 
II. ADJUVANT CHEMOTHERAPY 
 Cunningham - Marsden Regimen : (ECF Regimen) 
Epirubicin - 50 mg / m2 in 3 weekly boluses 
Cisplatin - 60 mg / m2 in 3 weekly boluses 
5-Fluorouracil-  200 mg / m2 daily by continuous infusion line for 3 weeks 
 For 6 cycles is the most widely accepted effective regimen at present. 
 South west oncology group (SWOG 9008) trial provides convincing 
evidence that a postoperative 5 fluorouracil (5FU) based chemoradiotherapy 
improves disease free and overall survival when compared with observation 
alone. 
Radical Palliative Resections : 
 
 Total gastrectomy 
 Oesophago gastrectomy 
 Partial gastrectomy 
 
Conservative Palliative surgeries : 
  
 Gastroenterostomy 
 Devine's exclusion by pass 
 Gastrostomy 
 Feeding jejunostomy 
 
Non surgical palliative procedures  : 
 
 Laser resection 
 (Reboring using Nd - YAG Laser) 
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III. ADJUVANT RADIOTHERAPY 
A British stomach cancer group study showed local recurrance rate was 
lowered with adjuvant radiotherapy (10% vs 27% with surgery alone) although 
U.S national cancer institute did not show any overall survival advantage. 
However improved local control was seen with adjuvant radiotherapy, 
compared with surgery alone. 
ADJUVANT CHEMORADIATION TREATMENT 
 Outcomes from Gastrointestinal intergroup trial of adjuvant 
chemoradiation for surgically resected gastric cancer show a major advantage 
in overall survival, disease free survival and loco - regional control with the use 
of adjuvant chemoradiation. 
RECENT ADVANCES 
 EARLY GASTRIC CANCER : (EGC) 
 Involving only mucosa and submucosa irrespective of lymphnode 
 Investigations : 
 1. Virtual endoscopy 
 2. Magnifying endoscopy 
 3. Flourescence endoscopy 
 4. Endoscopic USG 
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 Treatment Options : 
1. Endoscopic Mucosal Resection (EMR) : 
 - Grasp and pull technique 
  - Cut and suction technique 
 Indicated for lesions less than 2 cm size in the submucosal region 
2. Laparoscopic Endoluminal Resection : 
  For lesions in the posterior wall and near cardia or pylorus 
3. Laparoscopic Gastric Resection : 
 The conclusions from various studies in Japan showed mucosal 
tumors less than 3 cm size needs no lymphadenectomy; and submucosal and 
mucosal tumors greater than 3 cm size needed D4 dissection. 
NEOADJUVANT CHEMOTHERAPY 
 To date, the datas from various studies indicate no increase in operative 
morbidity or mortality with neoadjuvant chemotherapy. Although neoadjuvant 
chemotherapy proves to improve disease free survival rate from trials like 
MAGIC trial using ECF regimen before and after surgery final results are yet 
pending. 
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6.  PATIENTS AND METHODS 
 This study was carried out on 50 patients of Gastric Carcinoma in 
Surgical Wards of Government Kilpauk Medical College Hospital and 
Government Royapettah Hospital, Chennai, during the period, June 2004 to 
August 2007. 
 Initial work up included, clinical examination, hematological and 
biochemical parameters, barium studies, upper gastrointestinal endoscopy, 
Endoscopic biopsy and computerised tomography. 
 All deserving patients were explored with the basic intent of resection, 
even as a palliative measure. Patients however, found unresectable were 
subjected to palliative by pass. 
 Following surgery, histopathological examination of resected 
specimens, tumor morphology, differentiation, clearance of cut margins and 
level and status of lymphnodes studied. 
 Post operative adjuvant chemotherapy was given to patients, who after 
resection showed, involvement of lymphnodes, microscopic invasion of the cut 
margins, unfavorable histology and differentiation and presence of lymphatic 
or angio - invasion. Palliative chemotherapy was given to patients having 
unresectable disease. 
 Patients were followed up till the time of discharge from hospital. Post 
operative complication during the hospital stay were recorded. 
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GASTRIC CARCINOMA - PROFORMA 
Name:     Address: 
 
Age:     Occupation: 
 
Sex:     Hospital: 
 
Spcioeconomic Status 
 
I. Professional, Technical 
II. Clerical skills, sales 
III. Craftsman 
IV. Semiskilled 
V. Labourer 
VI. Farm labourers 
 
Symptoms      Signs 
Epigastric pain     Anemia 
Dyspepsia      Jaundice 
Vomiting      Malnourishment 
Early satiety      Epigastric lump 
Dysphagia      Ascites 
Melena      Visible gastric peristalsis 
Haematemesis     Secondaries liver 
Jaundice      Troisier's sign 
Ball rolling movements    Sister joseph's nodule 
Weight loss      Blumer's shelf 
Anorexia 
Asymptomatic 
 
Past H/o:      Investigations 
      
Drug intake      Hb% 
Previous surgery     OBT in stools 
       Liver function test 
       Barium meal study 
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Personal H/o:      UGI Scopy 
Smoking       USG Abdomen 
Alcoholism        CT scan abdomen 
Diet H/o       H-pylori study 
        Diagnostic laparoscopy 
Family H/o: 
 
MANAGEMENT: 
OPERATIVE FINDINGS 
 
1. Growth : Upper third 
    Middle third 
    Lower third 
    Diffuse 
 
2. Operability / resectability: 
 
3. Extent of lymphnode metastasis: 
 
  Perigastric (N1) 
  Coeliac axis (N2) 
  Root of mesentry (N3) 
  Paraaortic Nodes 
 
4. Extragastric spread: 
 
  Fixation to pancrease 
  Transverse colon 
  Transverse mesocolon 
  Pancreas 
  Peritoneal deposits 
  Blumers shelf 
  liver 
 
 
Chemotherapy: 
 
Post operative complications: Wound infection 
     Anastomotic leak 
     Stomal obstruction 
     Respiratory infection 
     Haemorrhage 
     Mortality 
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7.  OBSERVATIONS 
1. EPIDEMIOLOGY, AGE AND SEX INCIDENCE 
 Out of 50 patients, there are 35 males and 15 females, their age ranging 
from 28 years to 77 years; common in 5th and 6th decade (54%) with a mean 
age of 53 years. 
Age in Year Male Female Number Percent 
<30 0 1 1 2 
31-40 5 4 9 18 
41-50 10 3 13 26 
51-60 10 4 14 28 
61-70 9 3 12 24 
>70 1 0 1 2 
Total 35 15 50 100 
 
Range : 28 - 77 years 
M : F Ratio = 3.5 : 1.5 
2. SOCIOECONOMIC STATUS 
 
 In this study, class V and VI (Labourers and farmers) patients accounted 
for 70% while Class II, III and IV patients accounted for 24%. Only 6% of the 
patients belonged to class I (Professional, Technical Manager). 
Class Occupation Number Percent 
I Professional, Manager 3 6 
II Clerical Skills, Salesmen 6 12 
III Craftsmen 2 4 
IV Semiskilled 4 8 
V Labourer 20 40 
VI Farmer 15 30 
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3. PERSONAL HABITS   
 In this study, 72% of patients were smokers, smoked 4 cigarettes on 
average, for more than 10 years and 64% of patients were alcoholics, consumed 
at least once a week, 16% of patients were betelnut chewers. 68% of patients 
took spicy and salted foods regularly, 50% of patients had high starch diet 
derived from grains and tuberous roots. Only 12% of patients took vegetables 
and fruits regularly. 
Sl.No. Personal Habits Number Percent 
1. Smoking 36 72 
2. Alcohol 32 64 
3. Tobacco chewing 8 16 
4. Spicy & salted foods 34 68 
5. High starch diet 25 50 
6. Vegetables and fruits 6 12 
7. H.pylori (14 studied) 8 
(Out of 14) 
57% 
 
 Out of the 14 cases from which H-pylori study was done with biopsy 
material by staining with silver-starry stains 8 showed positive. 
4. SYMPTOMS AND SIGNS 
 Majority of the patients presented with epigastric pain, anorexia, 
vomiting and weight loss. Haemorrhage in the form of haematemesis or malena 
was much less frequent. Lump and anemia were the most frequent signs. The 
frequency of various symptoms and signs are given below. 
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Symptoms n Percent 
Epigastric pain 38 76 
Dyspepsia 32 64 
Weight Loss 40 80 
Anorexia 20 40 
Vomiting 35 70 
Malena 12 24 
Hematemesis 12 24 
 
Signs n Percent 
Anemia 42 84 
Epigastric Mass 20 40 
Visible Gastric Peristalsis 7 14 
Palpable Liver 4 8 
Jaundice 1 2 
Ascites 2 4 
 
The average duration of symptoms were 6 months to one year. 
5. BLOOD GROUPING 
 In this study group `A' accounted for 50% of patients, while O,B,AB 
accounted 30%, 14% and 6% respectively. 
Blood Group Number Percent 
O 15 30 
A 25 50 
B 7 14 
AB 3 6 
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6. BARIUM STUDY, ENDOSCOPY AND CT SCAN 
 In this study 50 patients were subjected to endoscopy and 20 patients 
were subjected to barium meal and 10 patients were subjected to CT scan. 
Their accuracy has been 89%, 70% and 90% respectively. 
Investigated 
Number 
Investigated 
Number 
Contributory 
Percent 
Accuracy 
UGI Endoscopy 50 49 98% 
Barium Meal 20 14 70% 
CT Scan 10 9 90% 
 
7. TREATMENT 
Surgery Number Percent 
Radical Total Gastrectomy 4 8 
Radical Partial Gastrectomy 11 22 
Palliative Total Gastrectomy 2 4 
Palliative Partial Gastrectomy 4 8 
Gastro Jejunostomy 19 38 
Feeding Jejunostomy 7 14 
Gastrostomy 1 2 
Biopsy and Closure 2 4 
 
Resections 
Study 
Curative Palliative 
By Pass 
Procedures 
No procedure 
attempted 
50 15 6 27 2 
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 Out of the 50 patients, who underwent laparotomy 2 of them had 
disseminated metastasis and are not suitable for any surgery. Curative resection 
was possible in about 15 patients and they underwent D1 resection. Remaining 
33 patients are suitable only for some palliative procedures. Obstruction, pain, 
Hematemesis were important reasons for palliation, being achieved by 
gastrectomy (6), gastrojejunostomy (19), feeding jejunostomy (7) and 
gastrostomy (1). 
8. EXTENT OF TUMOR 
 Lower third of the stomach (Antrum) has been the most common site, 11 
patients had involvement of more than one area. 7 patients had growth confined 
to cardia end of the stomach. In three patients whole stomach was involved. 
Site Number Percnet 
Cardia and Fundus 7 14 
Body and Antrum 8 16 
Confined to Body 5 10 
Confined to Antrum 27 54 
Diffuse Growth 3 6 
 
9. EXTENT OF LYMPHNODE METASTASIS (OPERATIVE 
FINDING) 
 More than half of our patients had perigastric lymphnodes involved 
within 3 cms from the primary lesion, while about 16% had no lymphnode 
involvement. 
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Extent Number Percent 
Node Negative (No) 8 16 
Perigastric (G1) 36 72 
Coeliac Axis (G2) 14 28 
Root of Mesentery (G3) 5 10 
Para Aortic 2 4 
 
10. EXTENT OF EXTRAGASTRIC SPREAD 
 In our patients liver and pancreas were the frequently involved intra 
abdominal organs. 
Extent Number Percent 
Fixation to Pancreas 18 36 
Transverse Mesocolon 4 8 
Transverse Colon 1 2 
Peritoneal Nodules 6 12 
Pelvic Floor 6 12 
Liver 12 24 
Extension to duodenum 3 6 
 
11. TUMOR MORPHOLOGY 
 Tumor morphology categorised based on Borrmann's Classification. 
ulcerative form (II) were most common. 
Type Number Percent 
Polypoid (I) 2 4 
Ulcerative (II) 32 64 
Crateriform (III) 10 20 
Diffuse (IV) 4 8 
Unclassified (V) 2 4 
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12. HISTOPATHOLOGY 
Adenocarcinoma Number Percent 
Well Differentiated 
¾ Mucinous 
¾ Papillary 
26 
23 
3 
52 
Moderately 
Differentiated 
9 18 
Poorly Differentiated 
¾ Signet Ring 
15 
3 
30 
 
 About 52% were well differentiated, of which 46% were mucin-
secreting type. About 30% were poorly differentiated of which 3 of them had 
signet ring pattern of cells. 
13. POST-OPERATIVE COMPLICATIONS 
Complications Number Percent 
Wound Infection 7 14 
Anastomotic Leak 1 2 
Stomal Obstruction 1 2 
Respiratory Infection 11 22 
Haemorrhage 1 2 
Mortality (within 10 days post operative) 3 6 
 
 Respiratory tract infection were the most common during their period of 
stay in our hospital, average stay being 12 days. About 3 patients died within 
10 days after lapartomy. The other common complication commonly observed 
in wound infection. 
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8. DISCUSSION 
The result of the present study, reflects the pattern of gastric carcinoma, 
tested in our hospital between June 2004 to August 2007. Most of the 
malignancies that occur are adenocarcinoma that shows a definite male 
predilection as with other studies. The highest age incidence was between 40 to 
60 years of age. Sedgwick, G.R. Giles, Dupout  and others have reported 
maximum age beyond 50-60 years of age. This shows that our patients are 
affected a decade or two earlier than patients abroad, confirming with other 
Indian studies on adenocarcinoma of stomach by Sarkar et al, B.R. Prabhakar 
and N. Rangabashyam.. 
 Large proportion of patients were farmers and labourers belonging to 
low socioeconomic group, reported similarly by kneller et al, Lawrence w.way 
and other most of them showed that, high incidence in low socio economic 
patients were due to malnutrition, which may increase the sensitivity of gastric 
mucosa to carcinogens, like N-nitroso compounds, H.pylori and dietary habits. 
 Though positive association was seen with smoking and alcoholism in 
this study, role of alcohol in the etiology of gastric cancer is doubtful in south 
studies. M.E. Craanen and others like T.D. Picton, D.A. Owen, Mac Donald 
have shown that smoking and alcohol are related to proximal tumour of 
stomach. 
 Several studies have attempted to establish the etiologic role of various 
food items in gastric cancer. The high starch diet, high salt intake, food 
contaminated with polycyclic hydrocarbons and insecticide used in vegetable  
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cultivation have been incriminated. Soil nitrite levels appear to correlate well 
with gastric cancer frequency. Dried salted fish, pickled vegetables have excess 
salt which acts as co carcinogen, thus enhancing  the effect of carcinogen. In 
our study more then 60% of patients were used to take salted and spicy foods 
and about 50% took high starch diet (Kanji) as breakfast daily. Only 12% of 
these patients regularly took vegetables and fruits. Fresh fruits and vegetables 
contain ascorbic acid which inhibits the chemical process of formation of 
nitrosamines and this may account for the reduced incidence of cancer. 
 A number of epidemiological studies seen to have shown that gastric 
cancer is more common in persons with blood Group A, than in those with 
blood group O and B. More than 55studies have supported this finding around 
the world. However the risk ratio for gastric cancer in persons with blood group 
A compared to those with blood group O is only a modest 1.2. 
The following table compares symptoms and signs with various studies. 
Symptoms and Signs Present Study N.Rangabashyam J.C.Hendricks
Epigastric Pain 76 60 90 
Dyspepsia 64 94 - 
Weight Loss 80 82 80 
Anorexia 40 - 60 
Vomiting 70 34 50 
Malena 24 10 20 
Haematemesis 24 - 15 
Asymptomatic - - 1 
Anemia 84 - 85 
Mass 40 72 30 
Distant Spread 8 20 5 
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 Majority of our patients presented with epigastric pain, vomiting either 
singly or in combination with dyspepsia, weight loss and anorexia. The number 
of patients, presenting with vomiting (70%) seems to be significantly high 
when compared with reports abroad. This shows that our patients report very 
late, after developing gastric outlet obstruction. Haemorrhage in the form of 
haematemesis was less frequent. No patient presented with metastatic disease 
as the presenting symptom. 
 Lump and anemia were the most frequent signs, confirming that our 
patients presented late with advanced disease. By the time physical signs of 
gastric cancer are present the disease is incurable. 
 In our study the percentage accuracy of various diagnostic investigations 
are comparable to the studies abroad. Computerized tomography was 90% 
accurate in diagnosing tumour and its extension. Upper gastro intestinal 
endoscopy diagnosed almost all the cases except one case from which biopsy 
was not conclusive. Barium meal was only 70% accurate compared with 
literature. 
 Compared to the western literatures, carcinoma of the antrum and body 
were more common in our study related by diet and environmental factors in 
our country which are more common in our country. However the percent of 
growth in the proximal stomach is about 14 percent and seems to be increasing 
in high socio-economic group patients in our country also. 
 The extent of the  tumour in our study compared to various other studies 
is shown : 
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Extent of the Tumor Present Study Warren Warwick 
Fixation to pancreas 36 10 7 
Transverse colon 2 6 4 
Transverse mesocolon 8 - - 
Peritoneal nodules 12 28 20 
Pelvic Floor 12 - - 
Liver 24 34 38 
 
Surgical procedure  for gastic cancer should be based on anatomical 
consideration, knowledge of natural history of disease and specific surgical 
goals curative or palliative - in a particular case. The extent of resection can be 
determined partly by the extent of the lesion and partly by the knowledge of its 
usual pathways of extension. 
References Year of Study % all Operation
% all 
Resection 
% 
Curative
Present Study 2004-2006 100 54 30 
Sharma. India 1961 73 36 - 
Cunningham et al., 
U.K. 
1974-84 84 49 39 
Cady et al., U.S.A. 1967-82 83 58 34 
Imanaga and 
Nakazato.Japan 
1964-73 100 80 61 
Boku et al., Japan 1975-1986 100 100 100 
 
The curative resection (Radical gastrectomy) is possible only in about 
30% patients. Of the remaining 70% of patients, 12% underwent palliative 
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resection and 54% underwent some bypass procedure. In 4% only biopsy was 
taken due to extensive disease.  
Randomized trials like bonenkamp et al and Cuschieri et al had proved 
there is no survival advantage of D2 resection over D1 resection, hence D2 
resection is not in practice except in Japan. All the curative resections done in 
our patients are D1 type resection. 
 
Number of 
Patients 
Type of 
Surgery 
Post operative 
complications 
Post 
operative 
mortality 
5 year 
survival 
Bonen Kamp  
et al., 
711 D1 
D2 
25 
43 
4 
10 
45 
47 
Cuschieri  
et al., 
400 D1 
D2 
28 
46 
6.5 
13 
35 
33 
 
Our resection rates in general, including both palliative and curative are 
comparable to most of western studies, but falls short by a significant margin 
when compared with the Japanese. This is because of the extensive screening 
methods developed in Japan, to detect early cancers. 
The immediate post-operative complication rate during the period of 
study is very much comparable with most of the studies abroad, except for 
respiratory tract and wound infection. The probable reason for highest 
pulmonary and wound infection rate could be due to the poor nutritional status, 
and personnel hygiene of our patients. Anastomotic complication are less in our 
patients probably because most of them underwent only palliative surgery. 
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Complication Present Study Adashek et al Diehl et al 
Wound infection 14 - 5 
Anastomotic leak 2 9 3 
Stomal obstruction 2 - - 
Respiratory infection 22 11 3 
Haemorrhage 2 4 0.5 
Mortality 6 1 -   
Predominant type of growth in this study was Type II ulcerative growth 
with everted margin, followed by Type III crateriform type of growth. In our 
country yet the most common site is distal third of stomach. In our study 54% 
of growth was confined to antrum and about 26% in the body and antrum. This 
is probably due to the low socioeconomic status, diet and environment factors 
and high prevalence of H.Pylori in our country. 
 T.D.Picton, J.W.Smith studies have observed a change in the site of 
origin of gastric carcinoma, with proximally located tumours becoming more 
prevalent. This relative increase is believed to be due to the decrease in the 
incidence of distally located tumor. M.E. craanen, W. Dekkar have observed 
that there is decrease in well differentiated adenocarcinoma and relative 
increase in the poorly differentiated type of adenocarcinoma. This is probably 
because of the relative increase in the involvement of cardia. In our study about 
50% are well differentiated adenocarcinomas compared to 30% poorly 
differentiated types. 
 Because of the effective screening procedures about 50% of the gastric 
cancers detected in Japan are Early Gastric Cancer confined to mucosa and 
submucosa. In our country most of them present only in an advanced stage 
suitable only for some palliative procedures.  
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9.  SUMMARY AND CONCLUSIONS 
* Gastric adeno carcinomas most commonly occurred between 4th and 5th 
decades, which is one or two decades earlier, when compared with 
Western countries and Japan. Male - Female ratio is 3.5 : 1.5. Farmers 
and labourers belonging to low socio economic group and patients with 
blood group `A' are more susceptible to the disease. 
* Strong association exists with smoking, alcohol, spicy and salted foods 
and high starch diet. Vegetables and fruits are associated with low 
incidence of gastric cancer. 
* Our patients present very late with obstruction, tumor fixation and 
extragastric spread, when compared to patients abroad. 
* Gastroscopy with biopsy, seems to be the most important investigation 
in the diagnosis of gastric cancer, with an accuracy 98% Barium meal 
has important role to play only in certain group of patients like linitis  
plastica, lymphomas and gastric stasis.  
* The most common site of growth still in India is the Antrum followed 
by Body, but proximal stomach cancers seem to be increasing compared 
with previous studies. 
* The most common type of growth is ulcerative type with everted 
margins (Type II Borrmann). Diffuse type is the least common. 
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* Most of our patients presented late with advanced disease amenable only 
for palliative resection or palliative by pass procedures. 
* Only a few patients underwent D1 type curative resection with 
histopathology showing tumor free margins. 
* Most of the tumor showed well differentiated mucinous type of 
adenocarcinoma which had good prognosis. 
* Wound infections and respiratory infections were the most common 
postoperative complications. 
* Early gastric cancer has a high percentage of curative resection rate but 
because of ineffective screening procedures the detection of early gastric 
cancer is almost nil. 
 Gastric Malignancy present us with many challenges. Even with the best 
surgical care available today, the advanced malignancy of stomach which we 
encounter will yield only poor results.  
EARLY DIAGNOSIS, FULLY DEVELOPED PREOPERATIVE 
STAGING AND AN AGGRESSIVE SURGICAL APPROACH PROVIDE 
THE BEST HOPE OF IMPROVING THE OUTLOOK FOR PATIENT 
WITH GASTRIC CANCER. 
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